Asmacure

Nicotinic receptor agonist compounds for the treatment of asthma and other inflammatory respiratory and non-respiratory diseases

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Asmacure plus 5393 other startups.